ZBH · Zimmer Biomet Holdings, Inc.

The departure of Suketu Upadhyay as CFO after seven years removes a key executive overseeing finance, operations, and supply chain at Zimmer Biomet, though explicitly not due to any disagreements on financials, controls, or practices, reducing concerns over internal issues. Paul Stellato's interim appointment provides continuity, leveraging his 20+ years of finance experience, including controllership, FP&A, and investor relations from prior roles at Xylem and ITT, plus his tenure at Zimmer Biomet since May 2022 where he has supported capital allocation and strategy. His dual role as principal financial and accounting officer ensures stability during the transition. Compensation for the interim role is competitive, with a $550,000 base, performance-tied bonus, and significant equity grants under existing plans, signaling board confidence. The active search for a permanent CFO underscores proactive management of leadership continuity amid ongoing strategy execution.